USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/19127
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSprincean, Mariana
dc.contributor.authorHadjiu, Svetlana
dc.contributor.authorCalcii, Cornelia
dc.contributor.authorLupușor, Nadejda
dc.contributor.authorGroppa, St.
dc.contributor.authorRevenco, Ninel
dc.date.accessioned2021-12-03T13:48:27Z
dc.date.available2021-12-03T13:48:27Z
dc.date.issued2021
dc.identifier.citationSPRINCEAN, Mariana, HADJIU, Svetlana, CALCII, Cornelia, LUPUSOR, Nadejda, GROPPA, St., REVENCO, Ninel. Immunoenzymatic assay of endoglin in ischemic stroke in children: [poster]. In: Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 20-22 octombrie 2021: culegere de postere. 2021, p. 168.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/19127
dc.descriptionNicolae Testemițanu State University of Medicine and Pharmacy, PHMI Institute of Mother and Child, National Epilepsy Center, Chisinau, Republic of Moldovaen_US
dc.description.abstractIntroduction. Stroke is a rare disease in children and adolescents, with an incidence of 2-13/100.000 children, and in the prenatal period - 1: 4000 of live births. Studies of stroke immune markers have become current. Purpose. Assessment of endoglin (CD105) in ischemic stroke (IS) in children to determine its role in early diagnosis and predictive factors of the disease. Material and methods. In 2017 − 2019 in the Republic of Moldova was carried out a prospective study on a sample of 53 children with IS (study sample, SS), investigated by ELISA in the acute phase of the process determining the serum levels of endoglin (CD105). At the same time, this marker was appreciated in 53 "practically healthy" children (control sample, CS). Results. In SS statistically significant endoglin values were found to be significantly lower than in CS (F = 84.812, p<0.001), maximum values (4.02 ng/ml) and minimum values (1.88 ng/ml). The mean level of endoglin, 2.06 ± 0.012 ng / ml in SS, does not exceed the level of 2.23 ng/ml, while in CS, the mean value of endoglin was 2.51 ± 0.071 ng/ml, has the maximum value of 4.02 ng/ml. Conclusions. In acute IS in children there is a significant decrease in serum endoglin, signifying its role as a biomarker of stroke and the need for therapeutic corrections indicated in cerebral ischemic processes. Experimental and clinical research on biomarkers promotes new discoveries in this field, to improve the diagnosis and treatment of IS in children.en_US
dc.language.isoenen_US
dc.publisherUniversitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" din Republica Moldovaen_US
dc.relation.ispartofConferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 20-22 octombrie 2021en_US
dc.subjectbiomarkersen_US
dc.subjectstrokeen_US
dc.subjectischemicen_US
dc.subjectchildrenen_US
dc.titleImmunoenzymatic assay of endoglin in ischemic stroke in childrenen_US
dc.typeOtheren_US
Appears in Collections:Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 20-22 octombrie 2021: Culegere de postere

Files in This Item:
File Description SizeFormat 
168_IMMUNOENZYMATIC_ASSAY_OF_ENDOGLIN_IN_ISCHEMIC_STROKE_IN_CHILDREN_Sprincean_Hadjiu.pdf478.71 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback